The United States Food and Drug Administration conducted inspection at Unichem Laboratories’ Active Pharmaceutical Ingredients manufacturing unit located at Roha between February 17 and 21. The inspection was a routine cGMP surveillance and successfully concluded without any FDA form 483 issued, it said in notices to stock exchanges. Shares of Unichem Laboratories closed 8.5 per cent higher at ₹148.25 on the BSE.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.